Chemically modified bovine beta-lactoglobulin blocks uptake of HIV-1 by colon- and cervix-derived epithelial cell lines.
Jiang
S
S
Lin
K
K
Strick
N
N
Li
Y Y
YY
Neurath
A R
AR
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002417:Cattle; D002584:Cervix Uteri / Q000821:virology; D003106:Colon / Q000821:virology; D004847:Epithelial Cells; D004848:Epithelium / Q000821:virology; D005260:Female; D015497:HIV-1 / Q000378:metabolism*; D006801:Humans; D007782:Lactoglobulins / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
C098082:3-hydroxyphthalic-beta-lactoglobulin; D000998:Antiviral Agents; D007782:Lactoglobulins